161 related articles for article (PubMed ID: 28990507)
21. Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
Kim SH; Weiß C; Hoffmann U; Borggrefe M; Akin I; Behnes M
Curr Pharm Biotechnol; 2017; 18(6):445-455. PubMed ID: 28571562
[TBL] [Abstract][Full Text] [Related]
22. Using metabolomics to assess myocardial metabolism and energetics in heart failure.
Turer AT
J Mol Cell Cardiol; 2013 Feb; 55():12-8. PubMed ID: 22982115
[TBL] [Abstract][Full Text] [Related]
23. Metabolomics and ischaemic heart disease.
Rasmiena AA; Ng TW; Meikle PJ
Clin Sci (Lond); 2013 Mar; 124(5):289-306. PubMed ID: 23157406
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics and cardiovascular imaging: a combined approach for cardiovascular ageing.
Koh AS; Kovalik JP
ESC Heart Fail; 2021 Jun; 8(3):1738-1750. PubMed ID: 33783981
[TBL] [Abstract][Full Text] [Related]
25. [Application and research advances of metabolomics in the field of orthopedics].
Sun Z; Qiu G; Zhao Y
Zhonghua Wai Ke Za Zhi; 2015 Jun; 53(6):476-80. PubMed ID: 26359065
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics in cardiovascular diseases.
Kordalewska M; Markuszewski MJ
J Pharm Biomed Anal; 2015 Sep; 113():121-36. PubMed ID: 25958299
[TBL] [Abstract][Full Text] [Related]
27. Nuclear magnetic resonance metabolomic profiling of Day 3 and 5 embryo culture medium does not predict pregnancy outcome in good prognosis patients: a prospective cohort study on single transferred embryos.
Kirkegaard K; Svane AS; Nielsen JS; Hindkjær JJ; Nielsen NC; Ingerslev HJ
Hum Reprod; 2014 Nov; 29(11):2413-20. PubMed ID: 25256566
[TBL] [Abstract][Full Text] [Related]
28. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
Serkova NJ; Niemann CU
Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics and Metabolic Diseases: Where Do We Stand?
Newgard CB
Cell Metab; 2017 Jan; 25(1):43-56. PubMed ID: 28094011
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.
Ruiz-Canela M; Hruby A; Clish CB; Liang L; Martínez-González MA; Hu FB
J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963102
[TBL] [Abstract][Full Text] [Related]
31. METABOLOMICS IN MEDICAL SCIENCES--TRENDS, CHALLENGES AND PERSPECTIVES.
Klupczyńska A; Dereziński P; Kokot ZJ
Acta Pol Pharm; 2015; 72(4):629-41. PubMed ID: 26647618
[TBL] [Abstract][Full Text] [Related]
32. Narrative review of metabolomics in cardiovascular disease.
Müller J; Bertsch T; Volke J; Schmid A; Klingbeil R; Metodiev Y; Karaca B; Kim SH; Lindner S; Schupp T; Kittel M; Poschet G; Akin I; Behnes M
J Thorac Dis; 2021 Apr; 13(4):2532-2550. PubMed ID: 34012599
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers of cardiac disease.
Marian AJ; Nambi V
Expert Rev Mol Diagn; 2004 Nov; 4(6):805-20. PubMed ID: 15525223
[TBL] [Abstract][Full Text] [Related]
34. Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications.
Amathieu R; Triba MN; Goossens C; Bouchemal N; Nahon P; Savarin P; Le Moyec L
World J Gastroenterol; 2016 Jan; 22(1):417-26. PubMed ID: 26755887
[TBL] [Abstract][Full Text] [Related]
35. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic Analysis in Heart Failure.
Ikegami R; Shimizu I; Yoshida Y; Minamino T
Circ J; 2017 Dec; 82(1):10-16. PubMed ID: 29225300
[TBL] [Abstract][Full Text] [Related]
37. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.
Zhang AH; Sun H; Qiu S; Wang XJ
Magn Reson Chem; 2013 Sep; 51(9):549-56. PubMed ID: 23828598
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in using mass spectrometry for mitochondrial metabolomics and lipidomics - A review.
Liu X; Xu G
Anal Chim Acta; 2018 Dec; 1037():3-12. PubMed ID: 30292306
[TBL] [Abstract][Full Text] [Related]
39. Metabolomic strategies to study lipotoxicity in cardiovascular disease.
Waterman CL; Kian-Kai C; Griffin JL
Biochim Biophys Acta; 2010 Mar; 1801(3):230-4. PubMed ID: 19944186
[TBL] [Abstract][Full Text] [Related]
40. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
